NGVT.NYSEIngevity CORP

Form 4: Ingevity Director Acquires Shares

Sentiment:

Statement of Changes in Beneficial Ownership


Director Francis David Segal acquired 329 shares of Ingevity Corp. common stock through vested deferred stock units.

Summary

  • Director Francis David Segal acquired 329 shares of Ingevity Corp. common stock on April 1, 2026.
  • The acquisition was made through vested deferred stock units (DSUs) granted in lieu of quarterly director fees.
  • These DSUs will convert into an equal number of common stock shares upon termination of board service.
  • The transaction price for the DSUs was $72.28 per share.
  • Following this transaction, Mr. Segal beneficially owns 6,380 shares of common stock directly.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event, as it represents a standard compensation mechanism for a director rather than a significant new investment or divestment.

Positives

  • Director acquisition of shares indicates confidence in the company's future.
  • The acquisition is a result of compensation for services rendered, aligning director interests with shareholders.
  • The number of shares acquired is modest, suggesting a routine compensation event rather than a significant personal investment.

Future Outlook

The DSUs are expected to settle into common stock upon the reporting person's termination of board service, as per the company's deferred compensation plan and incentive plan.

Industry Context

StockSavvy.ai notes that director stock acquisitions, particularly through deferred compensation plans, are common within the chemicals and materials sector as a method to retain and incentivize board members.

Stakeholder Impact

  • Shareholders: The acquisition by a director can be seen as a positive signal of commitment, though the impact is minimal as it's part of a compensation plan.
  • Employees: The transaction is a standard compensation practice for non-employee directors and does not directly impact employees.
  • Management: Reinforces the alignment of director compensation with company stock performance.

Next Steps

  • Settlement of vested deferred stock units into common stock upon termination of board service.

Key Dates

DateDescription
04/01/2026Transaction Date for acquisition of common stock via DSUs.
04/02/2026Date of filing of the Form 4 statement.

Keywords

Ingevity Corp, NGVT, Form 4, Director, Stock Acquisition, Deferred Stock Units, Beneficial Ownership

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.